G . Y. Lip

First name

G

Last name

. Y. Lip

van Staa, T. P., Setakis, E., Di Tanna, G. L., Lane, D. A., & . Y. Lip, G. (2011). A comparison of risk stratification schemes for stroke in 79,884 atrial fibrillation patients in general practice. J Thromb Haemost. http://doi.org/10.1111/j.1538-7836.2010.04085.x

View

Lee, S., Monz, B. U., Clemens, A., Brueckmann, M., & . Y. Lip, G. (2012). Representativeness of the dabigatran, apixaban and rivaroxaban clinical trial populations to real-world atrial fibrillation patients in the United Kingdom: a cross-sectional analysis using the General Practice Research Database. BMJ Open. http://doi.org/10.1136/bmjopen-2012-001768

View

Boggon, R., . Y. Lip, G., Gallagher, A. M., & van Staa, T. P. (2012). Resource utilization and outcomes in patients with atrial fibrillation: a case control study. Appl Health Econ Health Policy. http://doi.org/10.2165/11599940-000000000-00000

View